PacBio Announces Fourth Quarter and Fiscal Year 2024 Financial Results
MENLO PARK, Calif., Feb. 13, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) today announced financial results for the quarter and fiscal year ended December 31, 2024. Revenue of $39.2 million, a 33% ...
Blueprint Medicines should be bought on any weakness, says Stifel
Keeping a Buy rating and $155 price target on Blueprint Medicines (BPMC), Stifel says the market is disappointed that 2025 Ayvakit guidance ...
accountingweb.co.uk3d
See how an integrated suite helps your practice
Our FAB Hacks videos [1] are short videos from selected exhibitors at the 2025 Festival of Accounting & Bookkeeping (FAB) [2]. They will introduce you to ...